This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Biosimilars
Biosimilars
Benefits and cost-effectiveness of Nivestim™ for febrile neutropenia
EMA guides on monoclonal biosimilars
EMA releases revised biosimilar quality guideline
EMA to publish drug applications from March
European biosimilars market anticipates rapid growth
EMA releases biosimilar interferon-beta guide
Sandoz initiates two Phase III biosimilar trials
Recombinant human insulin biosimilars
Biosimilar insulins awaiting approval
Biosimilars in oncology: Optimal handling is required
Heparin: Generic or biosimilar?
Biosimilar monoclonal antibodies: The implications
« Previous
1
2
3
4
5
6
…
8
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: